C21 Investments Inc. — Cyborg Score 5/10

Mixed
Cannabis

Strategic Profile

The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets with multi-market branded consumer packaged goods (CPG). In fiscal year 2025, C21 Investments's revenue was $30.12 million, an increase of 12.42% compared to the previous year's $26.79 million.

Cyborg Score Rationale

C21 demonstrates solid operational execution with 12.4% revenue growth (fiscal 2025) and established market positions in Nevada and Oregon. However, the company faces headwinds from operating losses of $3.97 million in fiscal 2025 and ongoing regulatory/disclosure challenges, with OTC market trading reflecting elevated risk.

Top Insights

  • Vertically integrated operations span cultivation, processing, distribution, and retail across Nevada and Oregon markets with established CPG brands including Phantom Farms, Hood Oil, and Silver State Relief
  • Revenue grew 12.4% to $30.1M in fiscal 2025 (ended January 31, 2025), though company posted $3.97M operating loss
  • Q2 (July-September) sales reached $7.5 million, a 14% increase from Q1 sales of $6.6 million, indicating sequential momentum
  • Company maintains 138 full-time employees supporting multi-state operations

Named Competitors

  • Trulieve Cannabis — Multi-state cannabis retailer and cultivator
  • Curaleaf — Large multi-state cannabis operator
  • Phantom Farms — In-house CPG brand for flower and extracts

Recent Developments

  • (December 2025) Annual filings completed after prior regulatory delays
  • (November 2025) Ongoing quarterly reporting and operational updates
  • (September 2025) Q2 results showed 14% sequential sales growth

Open the full interactive C21 Investments Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →